December 2011 Monthly Message
PAN Weighs in to Help Make Clinical Trials More Efficient
The Common Rule is important to the Parkinson's community because it includes policies that protect individuals who participate in clinical trials. Because there are no treatments proven to slow, reverse, or prevent the progression of Parkinson's, let alone a cure for the disease, increasing the efficiency of clinical trials is of great importance to the Parkinson's community. Read more...
Meet Roger Halleen: PAN's Illinois State Director!
PAN's Illinois State Director, Roger Halleen, tells us why advocating on behalf of the Parkinson's community is important to him, and the methods of communication he prefers to use when reaching out to his elected officials. Read more...
Federal Deficit Reduction and Budget Update: A Busy December and Beyond
PAN's Director of Government Relations, Becca O'Connor, provides an overview of current federal budget negotiations, and what it means to the Parkinson's community. Read more...
Watch PAN's Webcast – "Why the FDA Matters to People with Parkinson's"
On Monday, December 12, the Parkinson's Action Network hosted an educational webcast about the Food and Drug Administration, and why its work is important to the Parkinson's community. Click here to watch!
PAN Needs Your Support!
As the end of the year approaches, PAN's Louisiana State Director and 2011 Milly Award recipient Michelle Lane asks for your support as part of your year-end giving plans. To learn more, click here.
Comcast Newsmakers Features CurePSP Foundation CEO Richard Gordon Zyne
Comcast interviewed Dr. Richard Gordon Zyne for a recent Newsmakers segment. Zyne talks about Parkinsonism, and what CurePSP is doing in the research and advocacy arenas to raise awareness about PSP, MSA, and other related disorders. Click here to watch the interview.